C12Y 204/01017
Glucuronosyltransferase
Official title: Glucuronosyltransferase (2.4.1.17)
C12Y204/01017 (Glucuronosyltransferase) appears on 82 US grants and 129 published applications in this corpus.
Search patents in C12Y- Granted patents
- 82
- Published applications
- 129
- Assignees
- 54
- Inventors
- 247
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 2 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 0 | 5 |
| 2016 | 5 | 11 |
| 2017 | 6 | 9 |
| 2018 | 8 | 17 |
| 2019 | 9 | 9 |
| 2020 | 10 | 10 |
| 2021 | 6 | 10 |
| 2022 | 11 | 11 |
| 2023 | 1 | 6 |
| 2024 | 8 | 12 |
| 2025 | 8 | 12 |
| 2026 | 2 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Glucuronosyltransferase, gene encoding same and method for using the same28 Jul 2026US 12,692,527 B2National Agriculture and Food Research Organization
- ABC transporters for the high efficiency production of rebaudiosides20 Jan 2026US 12,529,087 B2Amyris, Inc.
- Compositions and methods for silencing UGT1a1 gene expression23 Dec 2025US 12,503,699 B2Alnylam Pharmaceuticals, Inc.
- Uridine diphosphate-dependent glycosyltransferase enzyme25 Nov 2025US 12,478,082 B2Manus Bio Inc.
- Microbial production of mogrol and mogrosides25 Nov 2025US 12,480,146 B2Manus Bio Inc.
- Compositions and methods for silencing ugt1a1 gene expression1 Oct 2026US 2026/0297589 A1Alnylam Pharmaceuticals, Inc.
- Abc transporters for the high efficiency production of rebaudiosides3 Sep 2026US 2026/0258467 A1Amyris, Inc.
- Methods for making high intensity sweeteners3 Sep 2026US 2026/0258470 A1
- Glycoside product biosynthesis and recovery20 Aug 2026US 2026/0242839 A1Manus Bio Inc.
- Microbial production of mogrol and mogrosides18 Jun 2026US 2026/0167998 A1
Most cited
By later US patents
- Biocompatible implant for the expression and in vivo secretion of a therapeutic substance151US 5,906,817 AInstitut Pasteur · 1999
- Non-caloric sweeteners and methods for synthesizing38US 9,567,619 B2Conagen Inc. · 2017
- Non-caloric sweeteners and methods for synthesizing37US 9,643,990 B2Conagen Inc. · 2017
- Non-caloric sweeteners and methods for synthesizing33US 9,850,270 B2Conagen Inc. · 2017
- Non-caloric sweeteners and methods for synthesizing32US 9,783,566 B2Conagen Inc. · 2017